Evocalcet
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Evocalcet (trade name Orkedia) is a drug for the treatment of hyperparathyroidism. It acts as a calcium-sensing receptor agonist. In 2018, it was approved in Japan for treatment of secondary hyperparathyroidism in patients on dialysis.
Evocalcet (trade name Orkedia) is a drug for the treatment of hyperparathyroidism. It acts as a calcium-sensing receptor agonist. In 2018, it was approved in Japan for treatment of secondary hyperparathyroidism in patients on dialysis.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330817259 under CC BY-SA 4.0; modifications have been made.